Radiomics Model for Predicting Pulmonary Metastasis in Sarcoma Patients. Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e708
Date
10/03/2023Pubmed ID
37786072DOI
10.1016/j.ijrobp.2023.06.2202Abstract
PURPOSE/OBJECTIVE(S): The lung is the most common site of metastasis in localized extremity soft tissue sarcomas (STS). Indeterminant lung nodules leads to challenges for both patients and providers. As such, accuracy in the diagnosis of pulmonary metastasis (PM) is important for clinical decision making. The purpose of this is study is to develop and evaluate a CT-based radiomic model to predict PM in sarcoma patients with indeterminate pulmonary nodules.
MATERIALS/METHODS: Fifty-seven stage I-III sarcoma patients with indeterminate lung nodules on unenhanced CT that were approved for this study by our institution's internal review board (IRB). Twenty-two developed and categorized as PM and 35 without PM. A total number of 322 indeterminate nodules were investigated, where 165 & 157 nodules were from patients with and without PM, respectively. A total of 96 radiomic features (RF) (including first order statistics, 2d shape features, gray level co-occurrence, gray level size zone, gray level run length, neighboring gray tone difference & gray level dependence matrices) were taken from unenhanced CT images of each patient. We included 2D shape features since the size and shape of indeterminate lung nodules may have some correlation with PM. Spearman correlation were used to rule out redundant features (r2>0.9). T-test statistics was used to determine feature with significant differences that can differentiate responders with and without PM. Support Vector Machine (SVM) model was fitted to combinations of groups of 2-3 radiomic features. The AUC of the ROC curve was used to evaluate the model performance. Pointwise confidence intervals (CI) for AUC were calculated using 100 bootstrap replicates.
RESULTS: Four features were found significant after Spearman correlation and T-test statistical testing: 1. Maximum (MAX); 2. Minor Axis Length (MAL); 3. Gray Level Non-uniformity (GLNU); and 4. Interquartile Range (IR). The best performing 2-feature radiomic SVM model had an AUC of 0.69 (95% CI 0.61,0.74) for the MAX and GLNU features. The best performing 3-feature radiomic SVM model had an AUC of 0.74 (95% CI 0.70,0.80) for the MAX, MAL and IR features.
CONCLUSION: CT-based radiomics model has the potential to be used to predict PM in sarcoma patients presenting with indeterminate lung nodules. Additional research will focus on investigating derived parameters for existing RF, such as the ratio of the max RF to mean RF, to see if they improve the predictive performance of the model, as well as testing the models on external patient cohort. These radiomic models could be useful tools in guiding PM screening and providing a patient specific monitoring of sarcoma patients.
Author List
Prior PW Jr, Nasief HG, Mannem R, Charlson J, Fernando S, Bedi MAuthors
John A. Charlson MD Associate Professor in the Medicine department at Medical College of WisconsinRajeev Mannem MD Chief, Associate Professor in the Radiology department at Medical College of Wisconsin
